Valion Bio Inc (VBIO) Financials

$3.12

$0.05 (1.63%)

As on 02-Sep-2026 16:24EDT

Market cap

$1 Mln

Revenue (TTM)

$3 Mln

P/E Ratio

--

P/B Ratio

0.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19	Mar-18
Operating Revenue	2.50	0.38	--	1.18	1.84	--
Cost of Revenue	1.33	0.35	0.35	0.89	1.54	--
Gross Profit	-0.85	0.03	-0.35	0.29	0.30	--
Operating Expenses	14.44	7.90	4.48	8.53	10.40	2.34
Operating Profit (EBIT)	-14.99	-7.90	-4.48	-8.25	-10.10	-2.34
Other Income	--	--	--	--	--	1.46
Profit before Tax	-16.26	-7.99	-4.47	-8.24	-10.10	-0.88
Provision for Tax	--	--	--	--	--	--
Profit after Tax (Net Income)	-16.79	-8.76	-5.66	-8.24	-10.10	-0.88
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-0.88

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19	Mar-18
Shareholder's Funds	21.83	16.80	2.54	3.58	3.63	0.86
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	82.12	81.86	--	0.18	0.37	--
Current Liabilities	3.42	4.01	0.27	1.40	1.88	0.03
Total Liabilities	35.89	31.61	2.81	5.16	5.88	0.90

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19	Mar-18
Non-Current Assets	116.63	117.38	0.17	0.51	0.57	0.01
Current Assets	2.90	2.30	2.64	4.65	5.31	0.89
Total Assets	35.37	31.61	2.81	5.16	--	0.90
Total Debt*	0.40	0.50	--	0.37	--	--
Net Current Assets	--	12.36	2.37	3.25	3.43	0.85

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19	Mar-18
Cash From Operating Activities	--	-0.98	-5.73	-8.51	-8.92	-1.61
Cash Flow from Investing Activities	--	--	--	-0.12	-0.01	--
Cash from Financing Activities	--	0.16	4.33	8.51	-0.53	0.10
Net Cash Inflow / Outflow	--	--	--	--	--	-1.51

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19	Mar-18
Adjusted EPS ($)	-15.04	-39.43	-10.15	-0.16	-0.20	--
Cash EPS ($)	--	-39.41	-9.52	-0.16	-0.20	--
Adjusted Book Value ($)	--	75.59	4.55	0.07	0.07	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-4.42	-10.28	-0.17	-0.18	--
Free Cash Flow per Share ($)	--	-4.42	-10.28	-0.17	-0.18	--

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19	Mar-18
ROCE (%)	--	-88.35	-174.43	-217.55	--	-82.10
ROE (%)	-86.93	-90.64	-184.96	-228.68	--	-82.10
ROA (%)	-82.49	-50.92	-142.01	-149.46	--	-50.86
EBIT Margin (%)	-574.02	-2,067.54	--	-701.11	-548.80	--
Net Margin (%)	-671.01	-2,293.46	--	-701.02	-548.70	-60.44
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19	Mar-18
Revenue Growth (%)	--	--	-1.00	-0.36	--	--
EBIT Growth (%)	--	-76.69	45.79	18.35	--	36.68
Net Profit Growth (%)	--	-54.92	31.40	18.34	--	79.82
EPS Growth (%)	--	-2.88	-61.45	0.18	--	--
Book Value Growth (%)	-95.05	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19	Mar-18
Price / Earnings	--	-0.04	-0.58	-188.23	-5,464.89	--
Price / Book Value	0.12	0.02	1.29	433.45	15,199.33	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	0.06	-0.31	-192.08	-5,559.26	--
Close Price ($)	13.00	36.25	147.05	765.00	27,200.00	--
High Price ($)	140.00	391.00	952.00	36,125.00	172,975.00	--
Low Price ($)	11.51	35.00	85.43	488.75	21,675.00	--
Market Cap ($ Cr)	0.50	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19	Mar-18
Debt to Equity	--	0.03	--	0.10	--	--
Short term debt to equity ratio	0.02	0.03	--	0.05	--	--
Current Ratio	0.85	0.57	9.70	3.32	2.83	26.54
Quick Ratio	0.85	--	8.53	2.78	2.37	--
Interest Coverage	-21.58	-54.10	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19	Mar-18
Debtors to sales (%)	57.49	0.26	--	14.80	5.82	--
Asset Turnover	0.12	0.02	--	0.21	--	--
Receivable days	--	33.47	--	43.64	21.24	--
Inventory Days	--	332.90	557.73	332.59	204.55	--
Payable days	--	202.97	434.77	418.25	160.75	--
Cash Conversion Cycle	--	163.39	--	-42.03	65.04	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.